HALOFENATE
|
|
HALOFENATE Eigenschaften
- Siedepunkt:
- 551.1±50.0 °C(Predicted)
- Dichte
- 1.331±0.06 g/cm3(Predicted)
- pka
- 15.32±0.46(Predicted)
Sicherheit
HALOFENATE Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Halofenate is a selective peroxisome proliferator-activated receptor γ (PPARγ) modulator with antidiabetic activity.HALOFENATE Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
HALOFENATE Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 8)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
CLEARSYNTH LABS LTD. | -- |
sales@clearsynth.com | India | 6257 | 58 |
United States Biological | -- |
chemicals@usbio.net | United States | 6214 | 80 |
Leancare Ltd. | -- |
enquiry@leancare.co.uk | United Kingdom | 6446 | 42 |
Lanospharma Laboratories Co.,Ltd | -- |
sales@lanospharma.com | China | 6329 | 56 |
Shanghai New Union Textra Import & Export Co., Ltd | -- |
zhou@pharmchemical.com | China | 2748 | 60 |
2A PharmaChem USA | -- |
sales@2apharmachem.com | United States | 6137 | 39 |
3B Scientific Corporation | -- |
sales@3bsc.com | United States | 6718 | 47 |
AK Scientific, Inc. | -- |
sales@aksci.com | United States | 6347 | 65 |
26718-25-2()Verwandte Suche:
- HALOFENATE
- Lipivas
- MK-185
- Halofenatum
- 4-Chloro-α-[3-(trifluoromethyl)phenoxy]benzeneacetic acid 2-(acetylamino)ethyl ester
- Benzeneacetic acid, 4-chloro-α-[3-(trifluoromethyl)phenoxy]-, 2-(acetylamino)ethyl ester
- 26718-25-2
- C19H17ClF3NO4